Docstoc

289

Document Sample
289 Powered By Docstoc
					289

         ROSUVASTATIN REDUCES ATHEROSCLEROSIS
      INDEPENDENTLY OF ITS CHOLESTEROL-LOWERING
         EFFECT IN APOE3*LEIDEN TRANSGENIC MICE
 L.M. Havekes, W. Van Duyvenvoorde, M.C.E. Maas, H. Van Der Boom,
         C.M. Van Den Hoogen, J.J. Emeis, H.M.G. Princen
TNO Prevention and Health, Gaubius Laboratory, Leiden, The Netherlands
We investigated the effect of a new HMG-CoA reductase inhibitor,
rosuvastatin (Crestor), on the development of aortic atherosclerosis in the
apoE3*Leiden mouse, an established rodent model sensitive to the effects of
anti-hypercholesterolaemic and anti-atherosclerotic drugs. Hypercho-
lesterolaemia and atherosclerosis were induced by addition of 1%
cholesterol to the diet (HC group). A treatment group received the same diet
containing 0.005% w/w rosuvastatin (HC+R). An additional group received
lower amounts of cholesterol in the diet (LC) to parallel the plasma
cholesterol levels of the HC+R group, but without rosuvastatin treatment.
After 24 weeks treatment, rosuvastatin significantly reduced plasma
cholesterol and triglyceride levels by 25% and 45%, respectively (p<0.01),
compared to the HC control group. Overall plasma cholesterol exposure in
the HC+R and cholesterol-matched LC groups was comparable
(approximately 300mM/wk), and significantly lower than the HC group
(410 mM/wk, p<0.001). There was significant reduction in progression of
the aortic root total lesion area (-60%, p<0.001) and average lesion size
(-55%, p<0.001) in the LC group compared to the HC group. Compared to
the cholesterol-matched LC group, the HC+R group showed significant
additional reduction in total lesion area (-81%, p<0.001) and average lesion
size (-65%, p<0.001). Similar changes were seen in the aortic arch regions.
Compared to the HC and LC groups, in the HC+R group serum amyloid A
was reduced by 45% and 30%, respectively (p<0.001). Thus, rosuvastatin
elicited an additional significant reduction in the progression of aortic
atherosclerosis independently of its cholesterol lowering activity and
possibly via an anti-inflammatory action.

				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:6
posted:5/4/2011
language:English
pages:2